The First Affiliated Hospital of Sun Yat-sen University

Guangzhou 510080

2 studies enrolling now · 12 studies all time

What they study most

Acute Coronary Syndrome, Atrial Fibrillation, Childhood Idiopathic Nephrotic Syndrome, Crohn's Disease, Dermatitis, Atopic, GIST, Invasive Aspergillosis, Locally Advanced or Unresectable Metastatic Breast Cancer, Moderately to Severely Active Ulcerative Colitis, Non-small Cell Lung Cancer, Parkinson's Disease, Relapsing Multiple Sclerosis

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease — Recruiting now
• A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis — Running, not enrolling
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease — Starting soon
• A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28) — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• Olorofim Aspergillus Infection Study — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome — Running, not enrolling
• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy — Running, not enrolling
• (VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST — Completed